Proanthocycanidins from grape seeds inhibit expression of matrix metalloproteinases in human prostate carcinoma cells, which is associated with the inhibition of activation of MAPK and NFκB

Carcinogenesis

Volumn 25, Issue 6, 2004, Pages 987-995

  Vayalil, Praveen K ^a   Mittal, Anshu ^a   Katiyar, Santosh K ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANDROGEN; GELATIN; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; METRIBOLONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROANTHOCYANIDIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; PROTEINASE INHIBITOR;

ARTICLE; CANCER CELL CULTURE; CANCER MORTALITY; CAUSE OF DEATH; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; FIBROBLAST; GENE EXPRESSION REGULATION; GRAPE; HUMAN; HUMAN CELL; INHIBITION KINETICS; MALE; METASTASIS POTENTIAL; MOLECULAR RECOGNITION; PLANT SEED; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL; UNITED STATES; WESTERN BLOTTING; ZYMOGRAPHY; CELL DIVISION; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; PRENATAL DEVELOPMENT; PROSTATE TUMOR; TUMOR CELL LINE;

CELL DIVISION; CELL LINE, TUMOR; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; MATRIX METALLOPROTEINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PROANTHOCYANIDINS; PROSTATIC NEOPLASMS; PROTEASE INHIBITORS; SEEDS; VITIS;

EID: 3042778748     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh095     Document Type: Article

References (44)

1. Gronberg,H. (2003) Prostate cancer epidemiology. Lancet, 361, 859-864.
2. Jemal,A., Murray,T., Samuels,A., Ghafoor,A., Ward,E. and Thun,M.J. (2003) Cancer statistics, 2003. CA Cancer J. Clin., 53, 5-26.
3. Cancer Facts and Figures 2002 (2002) American Cancer Society, Inc., New York, pp. 3-15.
4. Greenlee,R.T., Hill-Harmon,M.B., Murray,T. and Thun,M. (2001) Cancer statistics, 2001. CA Cancer J. Clin., 51, 15-36.
5. Isaacs,J.T. (1999) The biology of hormone refractory prostate cancer. Why does it develop? Urol. Clin. North Am., 26, 263-273.
6. Harris,K.A. and Reese,D.M. (2001) Drugs, 61, 2177-2192.
7. Denmeade,S.R., Lin,X.S. and Isaacs,J.T. (1996) Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate, 28, 251-265.
8. Stetler-Stevenson,W.G., Aznavoorian,S. and Liotta,L.A. (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol., 9, 541-573.
9. Yu,A.E., Hewitt,R.E., Connor,E.W. and Stetler-Stevenson,W.G. (1997) Matrix metalloproteinases. Novel targets for directed cancer therapy. Drugs Aging, 11, 229-244.
10. Chambers,A.F. and Matrisian,L.M. (1997) Changing views of the role of matrix metalloproteinases in metastasis. J. Natl Cancer Inst., 89, 1260-1270.
11. John,A. and Tuszynski,G. (2001) The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res., 7, 14-23.
12. Nelson,A.R., Fingleton,B., Rothenberg,M.L. and Matrisian,L.M. (2000) Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol., 18, 1135-1149.
13. Kleiner,D.E. and Stetler-Stevenson,G. (1999) Matrix metalloproteinases and metastasis. Cancer Chemother. Pharmacol., 43S, 42-51.
14. Curran,S. and Murray,G.I. (2000) Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur. J. Cancer, 36, 1621-1630.
15. Egeblad,M. and Werb,Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nature Rev. Cancer, 2, 161-174.
16. Upadhyay,J., Shekarriz,B., Nemeth,J.A., Dong,Z., Cumming,G.D., Fridman,R., Sakr,W., Grignon,D.J. and Cher,M.L. (1999) Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia. Clin. Cancer Res., 5, 4105-4110.
17. Wilson,M.J., Sellers,R.G., Wiehr,C., Melamud,O., Pei,D. and Peehl,D.M. (2002) Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells. J. Cell Physiol., 191, 208-216.
18. Lokeshwar,B.L. (1999) MMP inhibition in prostate cancer. Ann. N.Y. Acad. Sci., 878, 271-289.
19. Westermarck,J. and Kahari,V.M. (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J., 13, 781-792.
20. Sternlicht,M.D. and Werb,Z. (2001) How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol., 17, 463-516.
21. Brawley,O.W., Barnes,S. and Parnes,H. (2001) The future of prostate cancer prevention. Ann. N.Y. Acad. Sci., 952, 145-152.
22. Miyake,H., Kato,S., Terasaki,M., Shigemori,M. and Morimatsu,M. (1998) Fibroblast growth factor-2 and -9 regulate proliferation and production of matrix metalloproteinases in human gliomas. Int. J. Oncol., 12, 1085-1090.
23. Miyake,H., Yoshimura,K., Hara,I., Eto,H., Arakawa,S. and Kamidono,S. (1997) Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines. J. Urol., 157, 2351-2355.
24. Klein,R.D., Maliner-Jongewaard,M.S., Udayakumar,T.S., Boyd,J.L., Nagle,R.B. and Bowden,G.T. (1999) Promatrilysin expression is induced by fibroblast growth factors in the prostatic carcinoma cell line LNCaP but not in normal primary prostate epithelial cells. Prostate, 41, 215-223.
25. Gabetta,B., Fuzzati,N., Griffini,A., Lolla,E., Pace,R., Ruffilli,T. and Peterlongo,F. (2000) Characterization of proanthocyanidins from grape seeds. Fitoterapia, 71, 162-175.
26. Sun,B.S., Belchior,G.P., Ricardo-Da-Silva,J.M. and Spranger,M.I. (1999) Isolation and purification of dimeric and trimeric procyanidins from grape seeds. J. Chromatogr. A, 841, 115-121.
27. Gali,H.U., Perchellet,E.M., Gao,X.M., Karchesy,J.J. and Perchellet,J.P. (1994) Comparison of the inhibitory effects of monomeric, dimeric, and trimeric procyanidins on the biochemical markers of skin tumor promotion in mouse epidermis in vivo. Planta Med., 60, 235-239.
28. Zhao,J., Wang,J., Chen,Y. and Agarwal,R. (1999) Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation-promotion protocol and identification of procyanidins B5-3′-gallate as the most effective antioxidant constituent. Carcinogenesis, 20, 1737-1745.
29. Joshi,S.S., Kuszynski,C.A. and Bagchi, D. (2001) The cellular and molecular basis of health benefits of grape seed proanthocyanidin extract. Curr. Pharm. Biotechnol., 2, 187-200.
30. Bagchi,D., Bagchi,M., Stohs,S.J., Ray,S.D., Sen,C.K. and Preuss,H.G. (2002) Cellular protection with proanthocyanidins derived from grape seeds. Ann. N.Y. Acad. Sci., 957, 260-270.
31. Agarwal,C., Singh,R.P. and Agarwal,R. (2002) Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome c release. Carcinogenesis, 23, 1869-1876.
32. Agarwal,C., Sharma,Y. and Agarwal,R. (2000) Anticarcinogenic effect of a polyphenolic fraction isolated from grape seeds in human prostate carcinoma DU145 cells: modulation of mitogenic signaling and cell-cycle regulators and induction of G1 arrest and apoptosis. Mol. Carcinogen., 28, 129-138.
33. Tyagi,A., Agarwal,R. and Agarwal,C. (2003) Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis. Oncogene, 22, 1302-1316.
34. Vayalil,P.K. and Katiyar,S.K. (2004) Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinase-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NFkB in human prostate carcinoma DU-145 cells. Prostate, 59, 33-42.
35. Mosmann,T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63.
36. Leber,T.M. and Balkwill,F.R. (1997) Zymography: a single-step staining method for quantitation of proteolytic activity on substrate gels. Anal. Biochem., 249, 24-28.
37. Katiyar,S.K., Afaq,F., Azizuddin,K. and Mukhtar,H. (2001) Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol. Appl. Pharmacol., 176, 110-117.
38. Dignam,J.D., Lebovitz,R.M. and Roeder,R.G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11, 1475-1489.
39. Van Steenbrugge,G.J., van Uffelen,C.J., Bolt,J. and Schroder,F.H. (1991) The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity. J. Steroid. Biochem. Mol. Biol., 40, 207-214.
40. Liao,X., Thrasher,J.B., Pelling,J., Holzbeierlein,J., Sang,Q-X.A. and Li,B. (2003) Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer. Endocrinology, 144, 1656-1663.
41. Forget,M.A, Desrosiers,R.R. and Beliveau,R. (1999) Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis. Can. J. Physiol. Pharmacol., 77, 465-480.
42. Gelmann,E.P. (2002) Molecular biology of the androgen receptor. J. Clin. Oncol., 20, 3001-3015.
43. Masiello,D., Cheng,S., Bubley,G.J., Lu,M.L. and Balk,S.P. (2002) Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor. J. Biol. Chem., 277, 26321-26326.
44. Mittal,A., Elmets,C.A. and Katiyar,S.K. (2003) Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation. Carcinogenesis, 24, 1379-1388.